Please assess the completion status of the following clinical trial:

Trial Title: Application of Tachosil During Lymphadenectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* cervical cancer (FIGO IA1, IA2, IB1, IB2)~* endometrial cancer (FIGO IA, IB, II)~* age between 18 and 70 years~* signed a written informed consent~Exclusion Criteria:~* lymph edema~* disease of the lymphatic system~* a known disease of the immune system

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- TACHOSIL GROUP (Type: ACTIVE_COMPARATOR): Surgical procedures were performed by four doctors with extensive experience in oncological gynecology. A TachoSil® absorbable patch of 4.8x4.8 cm was attached, once, intraoperatively to one side of the obturator fossa (study group). Specific drainage of the retroperitoneum was performed.
- GROUP WITHOUT TACHOSIL (Type: NO_INTERVENTION): The same patient constituted also control group, because no TachoSil® absorbable patche was used on the second side of lymphadenectomy. Specific drainage of the retroperitoneum was performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).